Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $0.54.

  • Bristol Myers Squibb's EPS (Basic) rose 125000.0% to $0.54 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.47, marking a year-over-year increase of 17850.68%. This contributed to the annual value of $3.47 for FY2025, which is 17868.48% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported EPS (Basic) of $0.54 as of Q4 2025, which was up 125000.0% from $1.08 recorded in Q3 2025.
  • Bristol Myers Squibb's EPS (Basic)'s 5-year high stood at $1.21 during Q1 2025, with a 5-year trough of -$5.89 in Q1 2024.
  • In the last 5 years, Bristol Myers Squibb's EPS (Basic) had a median value of $0.79 in 2024 and averaged $0.45.
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 127500.0% in 2021, then crashed by 64537.04% in 2024.
  • Bristol Myers Squibb's EPS (Basic) (Quarter) stood at $1.07 in 2021, then decreased by 10.28% to $0.96 in 2022, then fell by 9.38% to $0.87 in 2023, then plummeted by 95.4% to $0.04 in 2024, then surged by 1250.0% to $0.54 in 2025.
  • Its EPS (Basic) was $0.54 in Q4 2025, compared to $1.08 in Q3 2025 and $0.64 in Q2 2025.